Literature DB >> 10861404

A systematic approach to the validation of process control parameters for monoclonal antibody production in fed-batch culture of a murine myeloma.

E B Moran1, S T McGowan, J M McGuire, J E Frankland, I A Oyebade, W Waller, L C Archer, L O Morris, J Pandya, S R Nathan, L Smith, M L Cadette, J T Michalowski.   

Abstract

A systematic approach to the validation of control ranges of control parameters for a cell culture process producing a monoclonal antibody is described. Specifically, the structure and functional activity of a monoclonal IgG1 antibody produced at the outer limits of numerical ranges of fed-batch culture control parameters such as pH and temperature were examined, with the aim of providing assurance that antibody produced under varying culture conditions was of consistent quality based on a carefully defined set of specifications. An experimental design was created using a half-fractional factorial design for fed-batch culture incorporating half of the thirty two possible combinations of five selected control parameters at high and low levels. Statistical analysis of all data gathered from the study allowed an assessment of the effects of the process control parameters at either high or low outer limits on fed-batch culture response variables such as growth rate and specific antibody productivity. Measured values for the responses of growth rate and specific antibody productivity throughout this study ranged from 0.22-0.44 d(-1) and 6.4-32 microg monoclonal antibody/10(6) cells/d respectively. Analytical characterisation of monoclonal antibody purified from each fed-batch culture considered the purity, structure and biological activity of the glycoprotein. All antibody preparations were identical to each other and to the current antibody reference standard or control. Glycosylation analysis of certain samples from the study demonstrated that the distribution of glycoforms of the antibody was not affected by the varying process control conditions of the fed-batch cultures. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10861404     DOI: 10.1002/1097-0290(20000805)69:3<242::aid-bit2>3.0.co;2-i

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  4 in total

1.  Characterization of a monoclonal antibody cell culture production process using a quality by design approach.

Authors:  Brian Horvath; Melissa Mun; Michael W Laird
Journal:  Mol Biotechnol       Date:  2010-07       Impact factor: 2.695

2.  Digital Twins and Their Role in Model-Assisted Design of Experiments.

Authors:  Kim B Kuchemüller; Ralf Pörtner; Johannes Möller
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

3.  Transient transfection factors for high-level recombinant protein production in suspension cultured mammalian cells.

Authors:  Chaoting Liu; Brian Dalby; Weixing Chen; Jennifer M Kilzer; Henry C Chiou
Journal:  Mol Biotechnol       Date:  2008-06       Impact factor: 2.695

Review 4.  Clever Experimental Designs: Shortcuts for Better iPSC Differentiation.

Authors:  Ryota Yasui; Keisuke Sekine; Hideki Taniguchi
Journal:  Cells       Date:  2021-12-15       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.